¡Sorpréndeme!
Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
2022-02-26
4
Dailymotion
Videos relacionados
Laurus Labs In Focus | Ask Profit | NDTV Profit
Laurus Labs In Focus | Ask Profit | NDTV Profit
Ideas for Profit | Laurus Labs - a diversified portfolio of APIs and formulations.
Q1 Review | Laurus Labs' Founder Shares Earnings Insights
Q3 Review| Laurus Labs Growth Strategies For Coming Quarters
Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter
Laurus Labs Forays Into Biotech Segment Via Acquisition
Talking Point With Laurus Labs' Satyanarayana Chava
Laurus Labs In Focus | Profit Insight | NDTV Profit
Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
